Price movement over the last 24 hours
AdaptHealth Corp vs Sprott Uranium Miners ETF — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while Sprott Uranium Miners ETF trades at $51.24. The key difference: AdaptHealth Corp is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals.
| AHCO | URNM | |
|---|---|---|
Market Cap | $1.38B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $13.38 | $83.99 |
52-Week Low | $8.68 | $44.14 |
Enterprise Value | $3.33B | — |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
URNM trades at $53.56, up 1.38% today, but technical indicators signal a bearish trend with moving averages showing strong sell signals. The ETF is positioned at the intersection of AI-driven electricity demand and nuclear energy growth, with recent news highlighting uranium's role in powering data centers. Key support lies at $52, while resistance is near $54.
Outlook is mixed: long-term growth is supported by nuclear energy demand, but short-term risks include volatility in uranium prices and miner equity valuations. Investment opportunity hinges on the AI power narrative, yet caution is warranted due to technical weakness and concentrated miner exposure.
Trailing returns across standard periods
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →